This promotional website is for UK Healthcare Professionals involved in the management of haematological malignancies. Adverse event reporting information can be found below.
CLL Connections is an educational series of promotional meetings organised and funded by AbbVie for UK HCPs involved in the management of patients with haematological malignancies.
Welcome to CLL Connections
AbbVie is excited to announce its CLL Connections educational programme, helping those involved in the management of CLL to learn from peers in small-scale meetings, fostering a productive learning environment and exchange of insights on the first-line treatment of CLL.
Developed in collaboration with a group of haematologists, clinical nurse specialists and pharmacists, CLL Connections provides an opportunity to discuss and share best practice approaches with peers.
What you can expect:
Option of small group sizes to promote interactive discussions
Practical considerations of treatment
Perspectives from consultants, pharmacists and cancer nurse specialists
In-person and virtual meetings
Insights on the first-line CLL treatment landscape
Option of small group sizes to promote interactive discussions
Practical considerations of treatment
Perspectives from consultants, pharmacists and cancer nurse specialists
In-person and virtual meetings
Insights on the first-line CLL treatment landscape
With CLL Connections you have the opportunity to learn about one or more of the following topics:
Current treatment landscape in front-line CLL
Data supporting fixed-duration Venetoclax-based therapies
Onboarding patients with Venetoclax combinations
Approaches to capacity optimisation within clinics and day units
Discussions to support shared treatment decision-making
Current treatment landscape in front-line CLL
Data supporting fixed-duration Venetoclax-based therapies
Onboarding patients with Venetoclax combinations
Approaches to capacity optimisation within clinics and day units
Discussions to support shared treatment decision-making
REGISTER YOUR INTEREST IN
CLL CONNECTIONS
REGISTER YOUR INTEREST IN
CLL CONNECTIONS
CLL, Chronic lymphocytic leukaemia; HCP, Healthcare professional.
UK-VNCCLL-250140. Date of Preparation: May 2025
You are advised to read the Prescribing Information and Summary of Product Characteristics to evaluate patient suitability for VENCLYXTO.
VENCLYXTO PRESCRIBING INFORMATION
By clicking the link above you will leave the AbbVie Pro website and be taken to the eMC PI portal website.
